Rubicon Research Ltd Listed
Incorporated in 1999, Rubicon Research Limited is a pharmaceutical company engaged in the development, manufacturing, and commercialization of differentiated formulations.As of June 30, 2025, Rubicon Research had a...
GREY MARKET PREMIUM
+₹105
▲ +21.65% vs issue price
Issue Price
₹485.00
Est. Listing Price
₹590.00
Lot Size
30
Issue Details
Open Date
2025-10-09
Close Date
2025-10-13
Allotment
2025-10-14
Face Value
₹1.00
Total Issue Size
2,84,02,040 shares (aggregating up to ₹1,377.50 Cr) Cr
Issue Type
Bookbuilding IPO
Exchange
NSE & BSE
Financials (₹ Cr)
| Period | Revenue | PAT | EBITDA | Net Worth |
|---|---|---|---|---|
| 30 Jun 2025 | 356.95 | 43.30 | 79.74 | 593.67 |
| 31 Mar 2025 | 1296.22 | 134.36 | 267.89 | 540.98 |
| 31 Mar 2024 | 872.39 | 91.01 | 173.09 | 385.00 |
Key Ratios
Return on Equity
29.02
Return on Capital Employed
26.45
Return on Net Worth
29.02
PAT / Revenue
10.37
EBITDA / Revenue
20.67
Debt to Equity
0.73
Price to Book Value
13.65
EPS Pre-Issue
8.70
EPS Post-Issue
10.51
P/E Pre-Issue
55.75
P/E Post-Issue
46.13
Objects of the Issue
- Prepayment or scheduled repayment of all or a portion of certain outstanding borrowings availed by the Company — ₹310 Cr
- Funding inorganic growth through unidentified acquisitions and other strategic initiatives and General corporate purposes
Lead Managers
Axis Capital Ltd
IIFL Capital Services Ltd
JM Financial Ltd
SBI Capital Markets Ltd
Compare GMP Across IPOs
See how this IPO's GMP stacks up against every other live IPO.
Open GMP Charts →